Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hair Loss Prevention Study for Pancreatic Cancer

NCT: NCT04492800 · COMPLETED

NCT IDNCT04492800
StatusCOMPLETED
Start Date2019-12-13
Completion2021-12-31
SponsorHonorHealth Research Institute (OTHER)
First posted
Last updated

Brief Summary

Pilot study intended for hair loss prevention in patients with pancreatic cancer who are receiving treatment containing nab-paclitaxel, gemcitabine and cisplatin.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑